Sit Investment Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$46.9M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$27.2M |
| 3 |
Visa
V
|
+$22.8M |
| 4 |
Delta Air Lines
DAL
|
+$21.2M |
| 5 |
Brixmor Property Group
BRX
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRA
Diversified Real Asset Income Fd
DRA
|
+$26.4M |
| 2 |
Zimmer Biomet
ZBH
|
+$22.5M |
| 3 |
STJ
St Jude Medical
STJ
|
+$22M |
| 4 |
Johnson & Johnson
JNJ
|
+$19.8M |
| 5 |
Helmerich & Payne
HP
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.31% |
| 2 | Technology | 12.08% |
| 3 | Industrials | 11.14% |
| 4 | Financials | 9.57% |
| 5 | Consumer Discretionary | 9.31% |
Similar funds
Sit Investment Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Sit Investment Associates held 522 positions worth $5.46B, down 5.4% from $5.77B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Sit Investment Associates withdrew a net $240M in Q2 2015, closing 37 positions and reducing 173 holdings. Its most notable exit was Cummins, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
Against the trend, Sit Investment Associates opened a new position in Teva Pharmaceuticals worth $26.1M.
- Sit Investment Associates's largest Q2 2015 buy was Teva Pharmaceuticals: 441,660 shares worth $26.1M.
- Sit Investment Associates added most to Target in Q2 2015, an estimated $46.9M increase.
- Sit Investment Associates's biggest Q2 2015 reduction was Diversified Real Asset Income Fd, cutting an estimated $26.4M.
- Sit Investment Associates fully exited Cummins in Q2 2015, selling an estimated $19.5M.
- Sit Investment Associates's ten largest holdings make up 18% of its $5.46B portfolio in Q2 2015.
- Sit Investment Associates opened 96 new positions and closed 37 in Q2 2015.
- Sit Investment Associates's portfolio value fell 5.4% quarter-over-quarter to $5.46B.
Based on Sit Investment Associates's 13F filing for Q2 2015, filed 20 Jul 2015.